{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:48:23Z","timestamp":1776941303351,"version":"3.51.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T00:00:00Z","timestamp":1510704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000142","name":"Arthritis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MP3-139793"],"award-info":[{"award-number":["MP3-139793"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jclinepi.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Epidemiology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.jclinepi.2017.10.003","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T20:35:09Z","timestamp":1508186109000},"page":"56-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["A Bayesian model that jointly considers comparative effectiveness research and patients\u2019 preferences may help inform GRADE recommendations: an application to rheumatoid arthritis treatment recommendations"],"prefix":"10.1016","volume":"93","author":[{"given":"Glen S.","family":"Hazlewood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Bombardier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinepi.2017.10.003_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s11606-009-0987-8","article-title":"How well do guidelines incorporate evidence on patient preferences?","volume":"24","author":"Chong","year":"2009","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib2","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jclinepi.2014.07.005","article-title":"Adding a \u201cGRADE\u201d to the quality appraisal of rheumatoid arthritis guidelines identifies limitations beyond AGREE-II","volume":"67","author":"Hazlewood","year":"2014","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib3","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jama.300.4.436","article-title":"The next step in guideline development: incorporating patient preferences","volume":"300","author":"Krahn","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib4","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/jama.2013.281422","article-title":"The optimal practice of evidence-based medicine: incorporating patient preferences in practice guidelines","volume":"310","author":"Montori","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib5","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1056\/NEJMp1504245","article-title":"Medical facts versus value judgments\u2013toward preference-sensitive guidelines","volume":"372","author":"Ubel","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib6","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","article-title":"GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib8","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib9","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1136\/bmj.39493.646875.AE","article-title":"Going from evidence to recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib10","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jclinepi.2017.05.006","article-title":"The GRADE Working Group clarifies the construct of certainty of evidence","volume":"87","author":"Hultcrantz","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib11","first-page":"CD010227","article-title":"Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti-rheumatic drugs for rheumatoid arthritis: a network meta-analysis","author":"Hazlewood","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib12","doi-asserted-by":"crossref","first-page":"i1777","DOI":"10.1136\/bmj.i1777","article-title":"Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying antirheumatic drugs for rheumatoid arthritis: abridged Cochrane systematic review and network meta-analysis","volume":"353","author":"Hazlewood","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib13","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1093\/rheumatology\/kew280","article-title":"Treatment preferences of patients with early rheumatoid arthritis: a discrete-choice experiment","volume":"55","author":"Hazlewood","year":"2016","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib14","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/ije\/dys124","article-title":"Methods to convert continuous outcomes into odds ratios of treatment response and numbers needed to treat: meta-epidemiological study","volume":"41","author":"da Costa","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1037\/0033-2909.117.1.167","article-title":"Meta-analysis of screening and diagnostic tests","volume":"117","author":"Hasselblad","year":"1995","journal-title":"Psychol Bull"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib16","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","year":"2011"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib17","series-title":"Should I take etanercept (Enbrel\u00ae) for rheumatoid arthritis?: a Cochrane decision aid to discuss options with your doctor","author":"Rader","year":"2011"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib18","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhealeco.2008.11.003","article-title":"Bayesian and classical estimation of mixed logit: an application to genetic testing","volume":"28","author":"Regier","year":"2009","journal-title":"J Health Econ"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib19","series-title":"Discrete choice methods with simulation","author":"Train","year":"2009"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1303006","article-title":"Therapies for active rheumatoid arthritis after methotrexate failure","volume":"369","author":"O'Dell","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib21","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/art.34498","article-title":"A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of early aggressive rheumatoid arthritis trial","volume":"64","author":"Moreland","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib22","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib23","series-title":"Getting started with conjoint analysis: strategies for product design and pricing research","author":"Orme","year":"2005"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.39480","article-title":"2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib25","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib26","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/acr.22383","article-title":"Use of oral and subcutaneous methotrexate in rheumatoid arthritis patients in the United States","volume":"66","author":"Curtis","year":"2014","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jval.2015.12.003","article-title":"Multiple criteria decision analysis for health care decision making\u2013an introduction: report 1 of the ISPOR MCDA emerging Good practices Task Force","volume":"19","author":"Thokala","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib28","series-title":"Multiple criteria decision analysis: an integrated approach","author":"Belton","year":"2002"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib29","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1741-7015-11-159","article-title":"Is network meta-analysis as valid as standard pairwise meta-analysis? It all depends on the distribution of effect modifiers","volume":"11","author":"Jansen","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/acr.22758","article-title":"When patients write the guidelines: patient panel recommendations for the treatment of rheumatoid arthritis","volume":"68","author":"Fraenkel","year":"2016","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib31","doi-asserted-by":"crossref","first-page":"e1S","DOI":"10.1378\/chest.11-2290","article-title":"Patient values and preferences in decision making for antithrombotic therapy: a systematic review: antithrombotic therapy and prevention of Thrombosis, 9th ed.: American College of chest physicians evidence-based clinical practice guidelines","volume":"141","author":"MacLean","year":"2012","journal-title":"Chest"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib32","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/nep.12065","article-title":"ANZSN renal supportive care 2013: opinion pieces [corrected]","volume":"18","author":"Brown","year":"2013","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib33","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12955-017-0621-0","article-title":"Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach","volume":"15","author":"Zhang","year":"2017","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jclinepi.2016.09.009","article-title":"GRADE Evidence to Decision (EtD) frameworks for adoption, adaptation, and de novo development of trustworthy recommendations: GRADE-ADOLOPMENT","volume":"81","author":"Schunemann","year":"2017","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jclinepi.2017.10.003_bib35","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1377\/hlthaff.21.3.166","article-title":"Globalize the evidence, localize the decision: evidence-based medicine and international diversity","volume":"21","author":"Eisenberg","year":"2002","journal-title":"Health Aff (Millwood)"}],"container-title":["Journal of Clinical Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435616303092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0895435616303092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T17:45:53Z","timestamp":1668707153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0895435616303092"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":35,"alternative-id":["S0895435616303092"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinepi.2017.10.003","relation":{},"ISSN":["0895-4356"],"issn-type":[{"value":"0895-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Bayesian model that jointly considers comparative effectiveness research and patients\u2019 preferences may help inform GRADE recommendations: an application to rheumatoid arthritis treatment recommendations","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinepi.2017.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}